Tag: investigation

NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Archer-Daniels-Midland Company (NYSE: ADM) on behalf of long-term stockholders following a class action complaint that was filed against ADM on January 24, 2024 with a Class Period from April 30, 2020 through January 22, 2024. Our investigation concerns whether the board of directors of ADM have breached their fiduciary duties to the company.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In BellRing Brands (BRBR), KBR (KBR), Quantum (QMCO), or CTO (CTO) To Contact Him Directly To Discuss Their Options

PHILADELPHIA, July 14, 2025 (GLOBE NEWSWIRE) -- Berger Montague is investigating potential breaches of fiduciary duty and corporate governance failures at Aflac Inc. (“Aflac” or the “Company”) (NYSE: AFL) related to the Company’s recent cybersecurity breach.

The Hottest Country by Far

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Organon (OGN), UroGen (URGN), Red Cat (RCAT), or Fortrea (FTRE) To Contact Him Directly To Discuss Their Options

NEW YORK, July 12, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

NEW YORK, July 12, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

IOVA Investors with Losses Encouraged to Contact Hagens Berman Before July 14th Deadline

ATLANTA, July 11, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) complied with federal securities laws. On July 8, 2025, RxSight announced select preliminary financial results for the second quarter 2025 and revised full-year 2025 guidance, revealing declines in revenue, Light Delivery Devices sales, and usage of Light Adjustable Lenses. Following this news, the price of the Company’s stock dropped. 

NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Zynex, Inc. (NASDAQ:ZYXI) on behalf of long-term stockholders following a class action complaint that was filed against Zynex on July 9, 2025 with a Class Period from March 13, 2023, to the present. Our investigation concerns whether the board of directors of Zynex have breached their fiduciary duties to the company.